Ignite Creation Date:
2024-05-05 @ 4:57 PM
Last Modification Date:
2024-10-26 @ 9:26 AM
Study NCT ID:
NCT00351676
Status:
COMPLETED
Last Update Posted:
2007-12-11
First Post:
2006-07-12
Brief Title:
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment
Sponsor:
University of Alberta
Organization:
University of Alberta
Study Overview
Official Title:
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practising in a Team Environment COLLABORATE
Status:
COMPLETED
Status Verified Date:
2006-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We the researchers propose to link a clinical pharmacist with an internal medicine or family medicine team to provide pharmaceutical care to all patients assigned to the team The hypothesis is that through this team based approach pharmacists will act as a resource for providing pharmacotherapeutic advice during the drug therapy decision making process and promote optimal drug use by identifying and resolving actual and potential drug related problems This study is designed to test this hypothesis by assessing the impact of this intervention on evidence based quality of drug therapy indicators for patients admitted with heart failure HF chronic obstructive pulmonary disease COPD community acquired pneumonia CAP type 2 diabetes mellitus T2DM and stable coronary artery disease CAD
Detailed Description:
The overall goal of the COLLABORATE study is to improve processes of care and patient outcomes by optimizing drug therapy via a hospital pharmacy practice model that integrates clinical pharmacists into the patient care team
The intervention consists of a clinical pharmacist assigned to the patient care team for the purpose of providing proactive clinical pharmacy services The study pharmacist will be available during normal office hours 5 days per week to provide clarification of the patients medication history identify and resolve actual and potential patient specific drug related problemsissues participate in patient care rounds provide drug information to the patient care team provide patient education and discharge medication counselling and provide physician andor nursing staff education The anticipated pharmacist to patient ratio is approximately 120
Control patients will receive usual care Usual care consists of reactive clinical pharmacy services ie drug related issues identified as orders are received or by patient profile review provided by a ward based not team based clinical pharmacist
The intervention consists of a clinical pharmacist assigned to the patient care team for the purpose of providing proactive clinical pharmacy services The study pharmacist will be available during normal office hours 5 days per week to provide clarification of the patients medication history identify and resolve actual and potential patient specific drug related problemsissues participate in patient care rounds provide drug information to the patient care team provide patient education and discharge medication counselling and provide physician andor nursing staff education The anticipated pharmacist to patient ratio is approximately 120
Control patients will receive usual care Usual care consists of reactive clinical pharmacy services ie drug related issues identified as orders are received or by patient profile review provided by a ward based not team based clinical pharmacist
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None